155 related articles for article (PubMed ID: 24583540)
21. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
[TBL] [Abstract][Full Text] [Related]
22. Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study.
Moriwaki K; Matsumoto H; Tanishima S; Tanimura C; Osaki M; Nagashima H; Hagino H
BMC Musculoskelet Disord; 2019 Jun; 20(1):276. PubMed ID: 31164134
[TBL] [Abstract][Full Text] [Related]
23. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
[TBL] [Abstract][Full Text] [Related]
24. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
[TBL] [Abstract][Full Text] [Related]
25. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
[TBL] [Abstract][Full Text] [Related]
26. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
27. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
Korpela J; Tiitinen SL; Hiekkanen H; Halleen JM; Selander KS; Väänänen HK; Suominen P; Helenius H; Salminen E
Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645
[TBL] [Abstract][Full Text] [Related]
28. Markers of bone turnover: biochemical and clinical perspectives.
Pagani F; Francucci CM; Moro L
J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Bone Turnover Biomarkers in Lead-Battery Workers with Long-Term Exposure to Lead.
Kalahasthi R; Barman T; Bagepally BS
Int J Occup Environ Med; 2020 Jul; 11(3):140-147. PubMed ID: 32683426
[TBL] [Abstract][Full Text] [Related]
30. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
[TBL] [Abstract][Full Text] [Related]
31. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK
Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166
[TBL] [Abstract][Full Text] [Related]
32. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
[TBL] [Abstract][Full Text] [Related]
33. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K
Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470
[TBL] [Abstract][Full Text] [Related]
34. Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.
Nuche-Berenguer B; Moreno P; Esbrit P; Dapía S; Caeiro JR; Cancelas J; Haro-Mora JJ; Villanueva-Peñacarrillo ML
Calcif Tissue Int; 2009 Jun; 84(6):453-61. PubMed ID: 19219381
[TBL] [Abstract][Full Text] [Related]
35. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2009 Aug; 19(8):1075-82. PubMed ID: 19638690
[TBL] [Abstract][Full Text] [Related]
36. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
37. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.
Fischer DC; Mischek A; Wolf S; Rahn A; Salweski B; Kundt G; Haffner D
Ann Clin Biochem; 2012 Nov; 49(Pt 6):546-53. PubMed ID: 22984195
[TBL] [Abstract][Full Text] [Related]
38. Effects of treadmill exercise on bone mass, bone metabolism, and calciotropic hormones in young growing rats.
Iwamoto J; Shimamura C; Takeda T; Abe H; Ichimura S; Sato Y; Toyama Y
J Bone Miner Metab; 2004; 22(1):26-31. PubMed ID: 14691683
[TBL] [Abstract][Full Text] [Related]
39. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
40. Effects of a single bout of resistance exercise on calcium and bone metabolism in untrained young males.
Ashizawa N; Ouchi G; Fujimura R; Yoshida Y; Tokuyama K; Suzuki M
Calcif Tissue Int; 1998 Feb; 62(2):104-8. PubMed ID: 9437042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]